DAVA - Endava plc
| Previous Close | 36.21 |
| Open | 36.50 |
| Bid | 0.00 x 900 |
| Ask | 36.84 x 1000 |
| Day's Range | 36.10 - 38.78 |
| 52 Week Range | 21.13 - 38.78 |
| Volume | 402,301 |
| Avg. Volume | 125,017 |
| Market Cap | 1.794B |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | 86.40 |
| EPS (TTM) | 0.42 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2,460.42 |
Motley Fool•yesterdayEndava plc (DAVA) Q3 2019 Earnings Call Transcript
DAVA earnings call for the period ending March 31, 2019.
- ACCESSWIRE•2 days ago
Endava Plc Sponsored ADR Class A to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 21, 2019 / Endava Plc Sponsored ADR Class A (NYSE: DAVA ) will be discussing their earnings results in their 2019 Third Quarter Earnings to be held on May 21, 2019 at 8:00 ...
- Insider Monkey•20 days ago
Did Hedge Funds Drop The Ball On Endava plc (DAVA)?
During the fourth quarter the Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by nearly 7 percentage points as investors worried over the possible ramifications of rising interest rates. The hedge funds and institutional investors we track typically invest more in smaller-cap stocks than an average investor (i.e. only 298 S&P 500 […]
- Business Wire•29 days ago
Endava Announces Closing of Public Offering of ADSs by Existing Shareholders
Endava plc (DAVA) today announced the closing of an underwritten public offering of 5,750,000 American Depositary Shares (“ADSs”), each representing one Class A ordinary share of Endava, at a price to the public of $27.25 per ADS, all of which are being offering by existing shareholders of Endava.
- Benzinga•last month
The Daily Biotech Pulse: Hookipa To Debut, Mustang Bio Skyrockets, AngioDynamics Sheds Portfolio
Here's a roundup of top developments in the biotech space over the last 24 hours: No biotech stocks hit 52-week highs on Thursday. Down In The Dumps (Biotech stocks hitting 52-week lows on April 17) ABIOMED, ...
- Business Wire•last month
Endava Announces Pricing of Public Offering of ADSs by Existing Shareholders
Endava plc (DAVA) today announced the pricing of an underwritten public offering of 5,000,000 American Depositary Shares (“ADSs”), each representing one Class A ordinary share of Endava, at a price to the public of $27.25 per ADS, all of which are being offering by existing shareholders of Endava. Morgan Stanley & Co. LLC, Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC and Deutsche Bank Securities Inc. are acting as joint book-running managers for the offering. Cowen and Company, LLC, KeyBanc Capital Markets Inc. and William Blair & Company, L.L.C. are acting as co-managers for the offering.
- Simply Wall St.•last month
Is Endava plc's (NYSE:DAVA) 13% ROE Better Than Average?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. By way of learning-by-doing, w...
- Business Wire•last month
Endava Announces Proposed Public Offering of ADSs by Existing Shareholders
Endava plc (DAVA) today announced the launch of a proposed underwritten public offering of 5,000,000 American Depositary Shares (“ADSs”), each representing one Class A ordinary share of Endava, all of which are being offering by existing shareholders of Endava. Morgan Stanley & Co. LLC, Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC and Deutsche Bank Securities Inc. are acting as joint book-running managers for the offering. Cowen and Company, LLC, KeyBanc Capital Markets Inc. and William Blair & Company, L.L.C. are acting as co-managers for the offering.
- Zacks•2 months ago
The Zacks Analyst Blog Highlights: Rio Tinto, Smith & Nephew, Endava, AstraZeneca and British American Tobacco
The Zacks Analyst Blog Highlights: Rio Tinto, Smith & Nephew, Endava, AstraZeneca and British American Tobacco
- Zacks•2 months ago
Is Britain Headed for a Soft Brexit? 5 Picks
Following May's fresh legislative defeat, Britain could exit the EU while retaining access to its common market.
- Business Wire•3 months ago
Endava Announces Second Quarter Fiscal Year 2019 Results
Q2 FY201943.6%Year on Year Growth in Revenue to £71.8 million42.4% Constant Currency Revenue GrowthIFRS diluted EPS £0.14 compared to £0.10 in the prior year periodAdjusted diluted
- Simply Wall St.•3 months ago
Here’s What Endava plc’s (NYSE:DAVA) P/E Is Telling Us
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! This article is for investors who would like to improveRead More...
- Business Wire•3 months ago
Endava, London, U.K., Announces Date for Q2FY19 Earnings Release and Conference Call
Endava , a leading next-generation technology services provider, today announced it will release results for the second quarter ended December 31st, 2018, on Thursday February 28th, 2019 before the open of regular U.S.
- Simply Wall St.•4 months ago
Endava plc (NYSE:DAVA) Is Employing Capital Very Effectively
Today we'll look at Endava plc (NYSE:DAVA) and reflect on its potential as an investment. To be precise, we'll consider its Return On Capital Employed (ROCE), as that will inform Read More...
- Simply Wall St.•6 months ago
Is Endava plc’s (NYSE:DAVA) Balance Sheet A Threat To Its Future?
Endava plc (NYSE:DAVA) is a small-cap stock with a market capitalization of US$1.2b. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end Read More...
- Business Wire•6 months ago
Endava Announces Date for Q1 FY19 Earnings Release and Conference Call
Endava , a leading next-generation technology services provider, today announced it will release results for the first quarter ended September 30th, 2018, on Thursday November 29th, 2018 before the open of regular U.S.
- GlobeNewswire•6 months ago
Factors of Influence in 2018, Key Indicators and Opportunity within Sun Hydraulics, FIS, TRACON Pharmaceuticals, Kona Grill, Endava PLC Sponsored ADR, and Chembio Diagnostics — New Research Emphasizes Economic Growth
NEW YORK, Nov. 13, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- Simply Wall St.•7 months ago
Do Directors Own Endava plc (NYSE:DAVA) Shares?
Every investor in Endava plc (NYSE:DAVA) should be aware of the most powerful shareholder groups. Institutions often own shares in more established companies, while it’s not unusual to see insiders Read More...
- Thomson Reuters StreetEvents•7 months ago
Edited Transcript of DAVA earnings conference call or presentation 11-Oct-18 12:00pm GMT
Q4 2018 Endava PLC Earnings Call
Motley Fool•7 months agoEndava plc (DAVA) Q4 2018 Earnings Conference Call Transcript
DAVA earnings call for the period ending June 30, 2018.
- Business Wire•7 months ago
Bain & Company and Endava Announce Strategic Partnership
Bain & Company and Endava are pleased to announce they have entered into a global strategic partnership, combining Bain’s industry leading management consulting services with Endava’s world class strategy-led enterprise delivery and next-gen technology services. With technology playing an increasingly critical role in every aspect of business, companies recognize that they need to accelerate the development of digital solutions to ensure they remain on the competitive vanguard. The Bain-Endava partnership brings together deep skills in business and technology strategy, product ideation, technology development and deployment, and organizational change management to help support clients through successful transformations.
- Business Wire•7 months ago
Endava Announces Fourth Quarter FY18 and Full Year FY18 Financial Results
Q4 FY201842.8% Year over Year Growth in Revenue to £61.5 million 44.2% Constant Currency Revenue Growth1IFRS Diluted EPS £0.10 representing an 11% YoY increaseAdjusted diluted EPS2
